Retirement Group, LLC Amgen Inc Transaction History

Retirement Group, LLC

$268 Million
Q1 2024

A detailed history of Retirement Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Retirement Group, LLC holds 459 shares of AMGN stock, worth $132,132. This represents 0.05% of its overall portfolio holdings.

Number of Shares

459

Previous 459 -0.0%

Holding current value

$132,132

Previous $132,000 1.52%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $1,530 - $1,900	-7 Reduced 1.5%	459 $123,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $5,644 - $6,880	25 Added 5.67%	466 $113,000
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $91,612 - $116,404	400 Added 975.61%	441 $116,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $202,687 - $228,594	-903 Reduced 95.66%	41 $9,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $89,976 - $100,128	390 Added 70.4%	944 $230,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $5,043 - $5,579	23 Added 4.33%	554 $134,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $25,257 - $28,905	127 Added 31.44%	531 $119,000
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 11.01%	404 $101,000
Q4 2020 Feb 22, 2021	BUY	$216.38 - $257.67 $86,552 - $103,068	400 Added 740.74%	454 $104,000
Q3 2020 Nov 16, 2021	SELL	$234.65 - $260.95 $1.4 Million - $1.56 Million	-5,977 Reduced 99.1%	54 $14,000
Q3 2020 Sep 08, 2021	BUY	$234.65 - $260.95 $1.41 Million - $1.57 Million	6,027 Added 150675.0%	6,031 $494,000
Q4 2019 Aug 30, 2021	BUY	$189.21 - $243.2 $756 - $972	4 New	4 $1,000

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.

Account

Retirement Group, LLC Amgen Inc Transaction History